alvos terapêuticos para a correção do gene humano de distrofina por edição de gene e métodos de uso

trata-se de alvos terapêuticos para a correção do gene humano de distrofina por edição de gene e métodos de uso. Disclosed herein are therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use.

Saved in:
Bibliographic Details
Main Authors JACQUELINE N. ROBINSON-HAMM, CHARLES A. GERSBACH
Format Patent
LanguagePortuguese
Published 21.11.2018
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
COMPOSITIONS THEREOF
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
CULTURE MEDIA
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:trata-se de alvos terapêuticos para a correção do gene humano de distrofina por edição de gene e métodos de uso. Disclosed herein are therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use.
Bibliography:Application Number: BR20181111133